| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9b83d53426d0a3dfbb69a8826ec116d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2f399dc19ecdf6dde7928fc38221309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fea2f06afad402b2d50f4b6038aa021 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
1989-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03fcfd700ea134874fec9f0683225858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65fadcf74a93b843e43b43b0b1dd1e9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c63ab172ef6f61b9a4cfc9a94154d961 |
| publicationDate |
1992-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5087447-A |
| titleOfInvention |
Pharmaceutical preparations of high gastric acid binding capacity, delayed effect and of increased bioavailability |
| abstract |
The invention relates to a new pharmaceutical preparation of high acid-binding capacity, of delayed effect, of increased bioavailability for neutralization of gastric acid and optionally to other pharmaceutical preparations acting in the gastrointestinal tract, first of all of laxative effect by mixing 100 parts by mass of a powdered basic magnesium compound or the powdered mixture of basic magnesium compounds and basic aluminium compounds with 2-2500 parts of a dry or swollen organic acid of polymeric character and therapeutically acceptable, e.g. cellulose-glycolic acid, starch-glycolic acid or polymer acrylic and/or methacrylic acid, letting this powdered mixture to stand for 1-24 hours at the temperature of 20°-80° C. after addition of 50-500 parts by mass of water and forming tablets or other pharmaceutical preparations, optionally after addition of 5-60 parts by mass of smoothing agents and/or other pharmaceutical excipients, or transforming the mixture containing the basic active ingredients and the polymeric organic acid in liquid suspension by adding water and optionally excipients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011033401-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7998222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5880106-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005038077-A1 |
| priorityDate |
1986-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |